Small cell lung cancer treatment
Posted by omonon on October 9, 2008 in Cancer
Lung Cancer small cell lung cancer (SCLC) the highest degree of malignancy, the first transfer, but because of the SCLC further acts of awareness and the increase of new drugs and other reasons, can cure patients with more and more, to a certain extent, become a curable cancer One.
Small cell lung cancer chemotherapy for the high sensitivity, and more choice of chemotherapy and radiotherapy, surgery and treatment of traditional Chinese medicine;
(1 radiation therapy: anti-radiation effect on cancer cells. The better-performing small-cell lung cancer, followed by adenocarcinoma and squamous cell carcinoma. Dissatisfied with the results due to radiotherapy alone, Guchang with Chinese medicine.
(2) chemotherapy: small-cell lung cancer have a high degree of response to chemotherapy, so small cell lung cancer chemotherapy for the primary treatment, followed by squamous cell carcinoma, adenocarcinoma poor. At the same time, patients undergoing chemotherapy, there will be different levels of response, some patients have mild nausea and vomiting flu, but some patients may even be a bone marrow suppression, leukopenia, chemotherapy can not lead normal, so the need chemotherapy treatment with Chinese medicine In order to reduce the side effects of chemotherapy, improving the effectiveness of chemotherapy, so that in the course of treatment of cancer only a certain type of therapy can cure cancer is not realistic.
2, Chinese medicine treatment: The main treatment of lung cancer drug rehabilitation with the oral solution, Qingfei Sanjie pills, capsules compound cantharidin, Ankang Xin, Brucea javanica oil emulsion, such as oral drugs, “Pill Qingfei Sanjie” and “the Rehabilitation oral solution, “the best results, but also all existing drug treatment, only twolung cancer drug. More use of proprietary Chinese medicine as early as the main treatment, in advanced lung cancer (before or after surgery, radiotherapy and chemotherapy before and after the period of rehabilitation and cancer), now scientifically proven surgery and radiotherapy and chemotherapy alone is Zhibu Hao cancer with Chinese medicine before Is the best treatment. Can also cause lung cancer treatment by the cough, hemoptysis, chest tightness, Bieqi, anorexia, dry stool, abdominal distention Wan Man, nausea, vomiting, diarrhea, chest stagnant water, pain and other symptoms of lung cancer. At the same time China’s anti-cancer drug network in the treatment of patients taking the drug also free gift “Se fungus spore powder capsules”, containing rich in selenium elements (Selenium is a trace element, in particular the lack of cancer patients), and Fungus spores on broken capsule has a natural anti-cancer preventive health care, although no substitute for drug treatment, but can be treated with drugs, and promote the body’s absorption of the drug played a supplementary role, for which the Chinese anti-cancer drug network Launched a special purchase on the treatment of drug free gift offers ancillary products to cancer patients in the course of treatment can relieve some financial burden.
To Western medicine in the treatment of mainly + Fuzheng consolidate the treatment, supplemented by Western medicine to provide security, can reduce the surgery, radiotherapy and chemotherapy on the human body caused by injury and side effects, but also cover the recent Western medicine is effective, long-term effects of poor Shortcomings, real and thoroughly resolved patients with cancer surgery, radiotherapy and chemotherapy after the transfer and the recurrence of the problem.
Such therapy also provided the impetus for Chinese medicine, Chinese medicine treatment markedly effective to significantly reduce the time and completely broke the effects of Chinese medicine cancer slow, long course of the defects.
Small cell lung cancer treatment new progress report
According to the U.S. state of Tennessee NASHVILLE 2002120news: Vanderbilt-Ingram Cancer Center doctor said, application of new treatment methods to deal with a class of fatal small-cell lung cancer, to greatly extend the survival of patients provided hope.
Vanderbilt-Ingram American Thoracic Tumor Research Institute, Project Director Alan Sandler doctors in the January 9, 2002 published in The New England Journal of Medicine published in the Journal of the new treatment for patients with clinical trials in Japan, the United States is leading a large scale Research to in-depth evaluation of this method to extend the small-cell lung cancer patients survive the period of effectiveness in Japan for the clinical study recruited a total of 150 patients, researchers found that the patients impose drug CPT-11 (Camptosar or irinotecan) And cisplatin than the standard of cisplatin and Etoposide treatment more effective. Acceptable CPT-11-treated patients survive for a period in 2001 to raise the target by 55%, and to accept and rely on the cisplatin and Etoposide treatment of patients with Than, died of lung cancer and the risk of death factor also dropped by 40 percent. In addition to the 2-year survival probability of their more than three times.
“So far, we have not found a treatment can extend the survival time of patients to such an extent.” Sandler doctors said. “This difference was the first time the extra attention.”
In the United States, died of cancer caused by the death of all cases, according to the forefront of lung cancer. Each year, died of lung cancer than those who died of breast cancer, prostate cancer and colon cancer combined. And small-cell lung cancer in All types of lung cancer, is highly offensive, 2 / 3 of the patients in that, in the cancer has already begun large spread, so did the disease, with the average survival time (referring to Half the patients can live longer and half of the patients can live a shorter time to time) only 8-9 months.
“Now I can see the first patients and he said, ‘You live for another year of opportunity will exceed 50%,’” Sandler said. “To these patients, this means that they can see a wedding anniversary or grandchildren , The granddaughter of children born or secondary school graduates, they are not available before. ”
CPT-11 by blocking the topoisomerase cells to the proliferation of cancer cells interference. When the cell into two, one of DNA copy must depend on the success of this enzyme. The U.S. Food and Drug Administration in April 2000 approved the CPT-11 as a first-line treatment of metastatic carcinoma of the colon cancer recurrence or the standardization of drugs. And CPT-11 used in the early stages of these diseases is still in the effectiveness of the assessment phase.
Japan cooperative research group in 1995 started in Japan within the scope of this clinical study, by 1998 to accept the CPT-11 patients with drug therapy significantly extended the survival time ended.
The drug is the U.S. Phase III trial is to confirm that the Japanese patients in the U.S. administration will result in a considerable body of the response. Sandler doctors of the national study is the main researcher. Participate in the study may also include representatives from the Colorado University, Indiana University and a fee at the Fox Chase Cancer Center researchers. CPT-11 manufacturer Pharmacia Corporation has provided funding for research, the company early this year in the above three locations and other 25 local initiated the study.
The study is to compare drug CPT-11 and cisplatin with the standards of cisplatin and Etoposide the difference between the treatment. One of the patients randomly assigned to receive a certain treatment. 2 / 3 of patients will receive CPT-11 / – Platinum therapy. And a national clinical research will be a total of 300 patients participate.
Subscribe
Follow comments by subscribing to the Small cell lung cancer treatment Comments RSS feed.